ABOUT DDPDGENES

DDPDGENES is a Collaborative project funded by the European Commission under the 7th Framework Programme and is composed of 4 strong academic groups and 1 biotechnology company from 4 different European countries: Sweden, UK, Switzerland and Spain.

The DDPDGENES project started January 2012 and finalized in December 2015.   

PAST EVENTS

04/11/2015 Join us at the Parkinson's Open Day at Inbiomed in Donostia. Please visit our Facebook page (link below) for fotoreports on past events.

 

01/11/2015 DDPDGENES Fall Meeting to be celebrated in Donostia.

 

27/03/2015 Reserve this date and join us at the Parkinson's Open Day in Barcelona. 

 

25/03/2015 DDPDGENES Spring Meeting to be celebrated in Barcelona

 

22/03/2014 Join us at the Parkinson's Open Day at the John van Geest Centre for Brain Repair (in Cambridge). Read more in the Event's section

 

5/11/2013 Dr. Sten Linnarsson will be guest lecturer at the OUS-Rikshospitalet, Seminar room A3.3067 in Oslo, Norway.

 

10/12/2013 Dr. Roger Barker will speak at the XX World Congress on Parkinson Disease and related disorders in Geneva, Switzerland.

    

DDPDGENES IN THE SOCIAL NETWORKS

COMMITTEES AND PANELS

PROJECT STEERING COMMITTEE (PSC)

 

The Project Steering Committee (PSC) organizes regular meetings to guide the general execution of the DDPDGENES project and establishes the project boards and panels

 

Current members of the PSC are

 

  • Dr. Sten Linnarsson (KI, coordinator)
  • Dr. Ernest Arenas (KI)
  • Dr. Roger Barker (UCAM)
  • Dr. Jesper Ryge (EPFL)
  • Dr. Rosario Sanchez-Pernaute (Inbiomed)
  • Dr. Tamara Maes (Oryzon)

 

SCIENTIFIC ADVISORY BOARD

 

The Scientific Advisory Board (SAB) is external to the project and advises DDPDGENES on scientific decisions to taken in view of project results.

 

Current members of the SAB are

 

  • Professor Anders Björklund, Lund University
  • Professor Thomas Gasser, University of Tubingen

 

ETHICAL REVIEW PANEL

 

The Ethical review panel guarantees that all research performed in the DDPDGENES project involving human samples or animal studies strictly complies with European and local regulations.

 

Current members of the panel are

 

  • Dr. Roger Barker (UCAM)
  • Dr. Rosario Sanchez-Pernaute (Inbiomed)

DISSEMINATION PANEL

 

The Dissemination panel is responsible for the communication strategy of project results of the DDPDGENES project to the general public and to Parkinson patient organizations.

 

Current members of the panel are

 

  • Dr. Sten Linnarsson (UCAM)
  • Dr. Tamara Maes (Oryzon)